⌕
Liquidia · LQDA · Nasdaq
Tenet 55 · Mixed
Compare
$56.73+0.64%At closeTenet 55 · Mixed
$56.73+0.36 (+0.64%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Liquidia (LQDA) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

The percentage on each card is LQDA's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.

● Seeking AlphaNov 14, 2026 · 09:15 ET
Liquidia: Yutrepia's PAH Franchise Has Room To Grow

Liquidia kept the right to market YUTREPIA for PAH after the settlement with United Therapeutics. This settlement limits YUTREPIA's potential in PH-ILD, but since it can still be sold to patients using it and to patients…

LQDA +0.6% todayRead at source ↗
● Zacks Investment ResearchNov 11, 2026 · 13:40 ET
LQDA Q3 Earnings Beat Estimates on Robust Yutrepia Sales

Liquidia's Q3 earnings and revenues beat estimates as Yutrepia sales surge, while strong PAH demand and pipeline investments support growth.…

LQDA +0.6% todayRead at source ↗
● Zacks Investment ResearchNov 11, 2026 · 11:01 ET
LQDA Q3 Earnings Call Highlights Growth and Post-Settlement Outlook

Liquidia reports surging YUTREPIA sales, record October shipments and expanding PAH adoption amid post-settlement market changes and referral disruptions.…

LQDA +0.6% todayRead at source ↗
● Defense WorldNov 11, 2026 · 04:02 ET
Liquidia (NASDAQ:LQDA) Stock Price Breaks Above Fifty Day Moving Average Following Weak Earnings

Liquidia Corporation (NASDAQ: LQDA - Get Free Report) shares crossed above its 50 day moving average during trading on Tuesday following a better than expected earnings announcement. The stock has a 50 day moving average…

LQDA +0.6% todayRead at source ↗
● MarketBeatNov 10, 2026 · 13:16 ET
Liquidia Q3 Earnings Call Highlights

Liquidia NASDAQ: LQDA reported a 31% sequential increase in third-quarter YUTREPIA sales as the company sought to reassure investors that its pulmonary arterial hypertension business can continue growing following a pate…

LQDA +0.6% todayRead at source ↗
● Seeking AlphaNov 10, 2026 · 13:01 ET
Liquidia Corporation (LQDA) Q3 2026 Earnings Call Transcript

Liquidia Corporation (LQDA) Q3 2026 Earnings Call Transcript…

LQDA +0.6% todayRead at source ↗
● Zacks Investment ResearchNov 10, 2026 · 08:41 ET
Liquidia Corporation (LQDA) Q3 Earnings and Revenues Beat Estimates

Liquidia Corporation (LQDA) came out with quarterly earnings of $0.8 per share, beating the Zacks Consensus Estimate of $0.77 per share. This compares to a loss of $0.04 per share a year ago.…

LQDA +0.6% todayRead at source ↗
● GlobeNewsWireNov 10, 2026 · 08:00 ETCOMPANY'S OWN WORDS
Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference

MORRISVILLE, N.C., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced that Dr. Roger Jeffs, Chief Executive Officer, and Michael Kaseta, Chief Operating Officer and Chief Financial Offi…

LQDA +0.6% todayRead at source ↗
● GlobeNewsWireNov 10, 2026 · 06:30 ETCOMPANY'S OWN WORDS
Liquidia Corporation Reports Third Quarter 2026 Financial Results

MORRISVILLE, N.C., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and v…

LQDA +0.6% todayRead at source ↗
● GlobeNewsWireNov 3, 2026 · 08:30 ETCOMPANY'S OWN WORDS
Liquidia Corporation to Report Third Quarter 2026 Financial Results on November 10, 2026

MORRISVILLE, N.C., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and v…

LQDA +0.6% todayRead at source ↗
● Zacks Investment ResearchOct 28, 2026 · 12:50 ET
Liquidia Gears Up to Report Q3 Earnings: What Can Investors Expect?

LQDA's Q3 results will spotlight the impact of its legal settlement with UTHR, cash flow pressures, profitability prospects and pipeline progress.…

LQDA +0.6% todayRead at source ↗
● Zacks Investment ResearchOct 26, 2026 · 11:01 ET
Liquidia Corporation (LQDA) Earnings Expected to Grow: Should You Buy?

Liquidia Corporation (LQDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.…

LQDA +0.6% todayRead at source ↗
● Newsfile CorpOct 21, 2026 · 10:00 ET
Liquidia Corporation Investigation Continues: Investors May Contact Kirby McInerney LLP, a Securities Fraud Law Firm, If You Lost Money on Your LQDA Investments

New York, New York--(Newsfile Corp. - October 21, 2026) - The law firm of Kirby McInerney LLP continues its investigation on behalf of Liquidia Corporation ("Liquidia" or the "Company") (NASDAQ: LQDA) investors concernin…

LQDA +0.6% todayRead at source ↗
● Zacks Investment ResearchOct 14, 2026 · 14:41 ET
LQDA Settles UTHR Disputes for $380.7M, Limits Yutrepia Label

Liquidia settles six legal disputes with United Therapeutics, securing Yutrepia access for PAH patients but facing $380.7 million in payments and a narrower drug label.…

LQDA +0.6% todayRead at source ↗
● Proactive InvestorsOct 14, 2026 · 13:16 ET
Liquidia shares surge 25% as settlement ends United Therapeutics litigation

Liquidia Corporation (NASDAQ:LQDA), the biopharmaceutical company, surged 25% to $33.47 after settling all six pending lawsuits with United Therapeutics Corporation (NASDAQ:UTHR), ending years of patent and antitrust dis…

LQDA +0.6% todayRead at source ↗
● 24/7 Wall StreetOct 14, 2026 · 11:05 ET
United Therapeutics and Liquidia Just Ended Their Patent War. Liquidia Stock Popped 42%

A patent court ruling wiped out nearly half of Liquidia's stock value in a single day, and the settlement that followed cost the company almost every dollar it had in the bank.…

LQDA +0.6% todayRead at source ↗
● BenzingaOct 14, 2026 · 10:02 ET
Bending Spoons, Liquidia, Verastem And Other Big Stocks Moving Higher On Wednesday

U.S. stocks were mostly lower, with the Nasdaq Composite falling around 200 points on Wednesday.…

LQDA +0.6% todayRead at source ↗
● BarronsOct 14, 2026 · 08:57 ET
This Biotech Stock Surges 37% on Patent Settlement. ‘Better Than the Best-Case Scenario.

Liquidia surges after reaching a $380.7 million settlement with United Therapeutics resolving patent disputes for its lung disease drug.…

LQDA +0.6% todayRead at source ↗
● GlobeNewsWireOct 13, 2026 · 17:44 ETCOMPANY'S OWN WORDS
Liquidia Announces Global Settlement Resolving All Pending Litigation with United Therapeutics, Ensuring Continued Commercialization of YUTREPIA in PAH

MORRISVILLE, N.C., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and v…

LQDA +0.6% todayRead at source ↗
● PRNewsWireOct 12, 2026 · 14:55 ETCOMPANY'S OWN WORDS
Liquidia Corporation (LQDA) Securities Investigation Notice - Levi & Korsinsky

Liquidia shareholders took a roughly 57% loss after a court found that Yutrepia infringed two valid United Therapeutics patent claims. The investigation concerns whether investors had an accurate picture of that litigati…

LQDA +0.6% todayRead at source ↗
● Defense WorldOct 12, 2026 · 11:02 ET
Liquidia (NASDAQ:LQDA) Shares Gap Up – Here’s Why

Liquidia Corporation (NASDAQ: LQDA - Get Free Report)'s stock price gapped up prior to trading on Monday. The stock had previously closed at $27.38, but opened at $29.27. Liquidia shares last traded at $29.0220, with a v…

LQDA +0.6% todayRead at source ↗
● GlobeNewsWireOct 8, 2026 · 10:18 ET
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Liquidia Corporation (LQDA)

A reported 57% plunge followed a court finding against Yutrepia. That market reaction is now the focus of a Levi & Korsinsky investigation into potential securities law violations A reported 57% plunge followed a court f…

LQDA +0.6% todayRead at source ↗
● Business WireOct 7, 2026 · 22:50 ET
LQDA Investors with $100,000 in Losses Have Opportunity to Join Liquidia Corporation Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)---- $LQDA--LQDA Investors with $100,000 in Losses Have Opportunity to Join Liquidia Corporation Fraud Investigation with SBS Law.…

LQDA +0.6% todayRead at source ↗
● GlobeNewsWireOct 7, 2026 · 16:56 ETCOMPANY'S OWN WORDS
LIQUIDIA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Liquidia Corporation on Behalf of Liquidia Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Liquidia (LQDA) To Contact Him Directly To Discuss Their Options…

LQDA +0.6% todayRead at source ↗
● GlobeNewsWireOct 6, 2026 · 15:36 ET
LIQUIDIA CORPORATION INVESTIGATION: LQDA Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights

NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Liquidia Corporation (“Liquidia” or the “Company”) (NASDAQ: LQDA). The investigation concerns whet…

LQDA +0.6% todayRead at source ↗

Kept in their own lane. A press release is the company talking, not reporting.

No upcoming events in the feeds.

NVDA31−0.4%
WDAY4−5.8%
BBW3−2.6%

Article counts from the last market-wide feed page, across every symbol we track and not just LQDA · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.